Electra Therapeutics, Inc.: H.C. Wainwright initiates coverage with buy rating and $30 target price
ETRA•H.C. Wainwright initiated coverage of Electra Therapeutics, Inc. with a buy rating and a $30 target price.
Related News
Flutter Entertainment PLC: Stifel cuts target price to $125 from $133
FLUT•
Eledon’s Tegoprubart improves quality of life versus tacrolimus in Phase 2 kidney transplant trial
ELDN•
Molina Healthcare target price raised to $163 from $147
MOH•
InMode publishes shareholder letter from special committee
INMD•
Installed Building Products target price cut to $220 from $240
IBP•